Warning: The NCBI web site requires JavaScript to function. more...
Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.
Harms JS, Eakle KA, Kuo LS, Bremel RD, Splitter GA.
Genet Vaccines Ther. 2004 Aug 24;2(1):11.
Related citations
Growth inhibition of cancer cells by co-transfection of diphtheria toxin A-chain gene plasmid with bovine leukemia virus-tax expression vector.
Tana, Watarai S, Aida Y, Tajima S, Kakidani H, Onuma M, Kodama H.
Microbiol Immunol. 2001;45(6):447-55.
Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K, Spain C, Yen A, Overlid N, Gebremedhin S, Düzgüneş N.
Cell Mol Biol Lett. 2009;14(1):70-89. Epub 2008 Oct 6.
Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V, Heinz S, Bott D, Behrmann M, Covas DT, Seifried E, Tonn T.
Cytotherapy. 2007;9(8):785-94. Epub 2007 Oct 4.
Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus.
Kakidani H, Watarai S, Onuma M, Tomochika K, Yasuda T.
Microbiol Immunol. 1993;37(9):713-20.
Transcriptional regulation of the bovine leukemia virus promoter by the cyclic AMP-response element modulator tau isoform.
Nguyên TL, de Walque S, Veithen E, Dekoninck A, Martinelli V, de Launoit Y, Burny A, Harrod R, Van Lint C.
J Biol Chem. 2007 Jul 20;282(29):20854-67. Epub 2007 May 25.
Increase of antigen production in BLV-infected cell lines via additional expression of tax.
Wagner HJ, Blankenstein P, Bondzio A, Ebner D, Risse S.
Zentralbl Veterinarmed B. 1995 Nov;42(9):543-50.
Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.
Milan D, Nicolas JF.
J Virol. 1991 Apr;65(4):1938-45.
Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL, Jamil B, Maguire AJ, Alexander GJ, Lever AM.
J Gene Med. 2004 Sep;6(9):974-83.
Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S, Esumi N, Zack DJ, Campochiaro PA.
Gene Ther. 2006 May;13(9):798-804.
Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X, Olmsted-Davis E, Davis A, Liu S, Li Z, Yang J, Brunicardi FC.
World J Surg. 2006 Aug;30(8):1543-52.
Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells.
Klener P, Szynal M, Cleuter Y, Merimi M, Duvillier H, Lallemand F, Bagnis C, Griebel P, Sotiriou C, Burny A, Martiat P, Van den Broeke A.
J Virol. 2006 Feb;80(4):1922-38.
Differential expression of mammalian or viral promoter-driven gene in adherent versus suspension cells.
Feng G, Hicks P, Chang PL.
In Vitro Cell Dev Biol Anim. 2003 Nov-Dec;39(10):420-3.
A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.
Tajima S, Takahashi M, Takeshima SN, Konnai S, Yin SA, Watarai S, Tanaka Y, Onuma M, Okada K, Aida Y.
J Virol. 2003 Feb;77(3):1894-903.
Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
Breast Cancer Res Treat. 2009 Sep;117(1):45-54. Epub 2008 Sep 13.
Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters.
Wright A, Semyonov A, Dawes G, Crameri A, Lyons R, Stemmer WP, Apt D, Punnonen J.
Hum Gene Ther. 2005 Jul;16(7):881-92.
Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors.
Gruh I, Wunderlich S, Winkler M, Schwanke K, Heinke J, Blömer U, Ruhparwar A, Rohde B, Li RK, Haverich A, Martin U.
J Gene Med. 2008 Jan;10(1):21-32.
Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo.
Liu B, Paton JF, Kasparov S.
BMC Biotechnol. 2008 May 16;8:49.
Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo.
Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, Xiao S.
Exp Mol Med. 2007 Apr 30;39(2):170-5.
Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI, Kang JH, Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC.
J Nucl Med. 2007 Sep;48(9):1553-61. Epub 2007 Aug 17.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on